NCT01029405View on ClinicalTrials.gov

Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis

PHASE2CompletedINTERVENTIONAL

Enrollment

145

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

June 30, 2010

Conditions

Psoriasis

Interventions

DRUG

AN2728

Ointment B, 2% or 0.5% applied once or twice daily

DRUG

Placebo

Ointment B Vehicle applied once or twice daily

Trial Locations (5)

Unknown

Chihuahua City

Mexico City

Zapopan

Monterrey

San Luis Potosí City

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT01029405 - Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis | Biotech Hunter | Biotech Hunter